HARRISON, James,FULLER, Stephen,BROWN, Tobias Josef
申请号：
LT15700003
公开号：
LT3089740T
申请日:
2015.01.05
申请国别(地区):
LT
年份:
2020
代理人:
摘要：
The present invention relates to oral pharmaceutical compositions comprising nitisinone, or a pharmaceutically acceptable salt thereof, their use in the treatment of tyrosinemia, such as Hereditary Tyrosinemia type-1 (HT-1), or alkaptonuria. The compositions have improved stability characteristics. The invention also relates to processes for producing nitisinone.
